HIV infection does not prevent the metabolic benefits of diet-induced weight loss in women with obesity

Obesity

Volumn 25, Issue 4, 2017, Pages 682-688

  Reeds, Dominic N ^a   Pietka, Terri A ^a   Yarasheski, Kevin E ^a   Cade, W Todd ^a   Patterson, Bruce W ^a   Okunade, Adewole ^a   Abumrad, Nada A ^a   Klein, Samuel ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ATAZANAVIR; AUTOPHAGY RELATED PROTEIN 7; C PEPTIDE; CCAAT ENHANCER BINDING PROTEIN; CD11B ANTIGEN; DARUNAVIR; E1B PROTEIN; EFAVIRENZ; EMTRICITABINE; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INSULIN; INTERLEUKIN 6; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEVIRAPINE; PALMITIC ACID; PROTEIN P53; RALTEGRAVIR; SERINE THREONINE PROTEIN KINASE ULK1; TENOFOVIR; TRANSCRIPTION FACTOR FKHRL1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; X BOX BINDING PROTEIN 1; AUTACOID;

ADIPOSE TISSUE; ADULT; ARTICLE; AUTOPHAGY; BODY COMPOSITION; CHOP GENE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; EMR1 GENE; ENDOPLASMIC RETICULUM STRESS; FAT FREE MASS; FEMALE; GENE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GRP78 GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; IL 6 GENE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAPERITONEAL FAT; ITGAM GENE; ITGAX GENE; LIVER; LOW CALORY DIET; MCP1 GENE; MRC2 GENE; OBESITY; PROSPECTIVE STUDY; SKELETAL MUSCLE; SYSTOLIC BLOOD PRESSURE; TNF ALPHA GENE; WEIGHT REDUCTION; XBP1 GENE; CLINICAL TRIAL; COMPLICATION; DIET THERAPY; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY; PROCEDURES; SERODIAGNOSIS; VIROLOGY;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; DIET, REDUCING; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HIV INFECTIONS; HIV SERONEGATIVITY; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; LIVER; MUSCLE, SKELETAL; OBESITY; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 85014273398     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21793     Document Type: Article

References (40)

1. Mondy K, Overton ET, Grubb J, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007;44:726–734.
2. Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007;45:1074–1081.
3. Koethe JR, Jenkins CA, Lau B, et al. Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Res Hum Retroviruses 2016;32:50–58.
4. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005;165:1179–1184.
5. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506–2512.
6. Womack JA, Chang CC, So-Armah KA, et al. HIV infection and cardiovascular disease in women. J Am Heart Assoc 2014;3:e001035. doi:10.1161/JAHA.114.001035.
7. Brown TT, Tassiopoulos K, Bosch RJ, Shikuma C, McComsey GA. Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy. Diabetes Care 2010;33:2244–2249.
8. Murata H, Hruz PW, Mueckler M. The mechanism of insulin resistance caused by HIV protease inhibitor therapy. J Biol Chem 2000;275:20251–20254.
9. Zhang S, Carper MJ, Lei X, Cade WT, Yarasheski KE, Ramanadham S. Protease inhibitors used in the treatment of HIV+ induce beta-cell apoptosis via the mitochondrial pathway and compromise insulin secretion. Am J Physiol Endocrionol Metab 2009;296:E925–E935.
10. Djedaini M, Peraldi P, Drici MD, et al. Lopinavir co-induces insulin resistance and ER stress in human adipocytes. Biochem Biophys Res Commun 2009;386:96–100.
11. Kraus M, Malenke E, Gogel J, et al. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis. Mol Cancer Ther 2008;7:1940–1948.
12. Nunez CE, Rodrigues VS, Gomes FS, et al. Defective regulation of adipose tissue autophagy in obesity. Int J Obes (Lond) 2013;37:1473–1480.
13. Yang L, Li P, Fu S, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2010;11:467–478.
14. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992;56:320–328.
15. Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S. Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology 2009;136:1552–1560.
16. Aberg JA, Kaplan JE, Libman H, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009;49:651–681.
17. Engelson ES, Agin D, Kenya S, et al. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Metabolism 2006;55:1327–1336.
18. Fitch KV, Anderson EJ, Hubbard JL, et al. Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome. AIDS (London, England) 2006;20:1843–1850.
19. American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care 2016;39(Suppl 1):S13–S24.
20. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–3421.
21. Genton L, Hans D, Kyle UG, Pichard C. Dual-energy X-ray absorptiometry and body composition: differences between devices and comparison with reference methods. Nutrition 2002;18:66–70.
22. Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008;134:1369–1375.
23. Frimel TN, Deivanayagam S, Bashir A, O'Connor R, Klein S. Assessment of intrahepatic triglyceride content using magnetic resonance spectroscopy. J Cardiometab Syndr 2007;2:136–138.
24. Jensen MD, Heiling VJ. Heated hand vein blood is satisfactory for measurements during free fatty acid kinetic studies. Metabolism 1991;40:406–409.
25. Reeds DN, Mohammed BS, Klein S, Boswell CB, Young VL. Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial. Aesthet Surg J 2013;33:400–408.
26. Reeds DN, Mittendorfer B, Patterson BW, Powderly WG, Yarasheski KE, Klein S. Alterations in lipid kinetics in men with HIV-dyslipidemia. Am Journal Physiol Endocrionol Metab 2003;285:E490–E497.
27. Patterson BW, Zhao G, Elias N, Hachey DL, Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 1999;40:2118–2124.
28. Horowitz JF, Coppack SW, Klein S. Whole-body and adipose tissue glucose metabolism in response to short-term fasting in lean and obese women. Am J Clin Nutr 2001;73:517–522.
29. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959;82:420–430.
30. Conte C, Fabbrini E, Kars M, Mittendorfer B, Patterson BW, Klein S. Multiorgan insulin sensitivity in lean and obese subjects. Diabetes Care 2012;35:1316–1321.
31. Cutrono SE, Lewis JE, Perry A, Signorile J, Tiozzo E, Jacobs KA. The effect of a community-based exercise program on inflammation, metabolic risk, and fitness levels among persons living with HIV/AIDS. AIDS Behav 2016;20:1123–1131.
32. Tomaka F, Lefebvre E, Sekar V, et al. Effects of ritonavir-boosted darunavir vs. ritonavir-boosted atazanavir on lipid and glucose parameters in HIV-negative, healthy volunteers. HIV Med 2009;10:318–327.
33. Venhoff N, Setzer B, Melkaoui K, Walker UA. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antivir Ther 2007;12:1075–1085.
34. Guffanti M, Caumo A, Galli L, et al. Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects. Eur J Endocrinol 2007;156:503–509.
35. Magkos F, Fabbrini E, Korenblat K, Okunade AL, Patterson BW, Klein S. Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease. Int J Obes (Lond) 2011;35:1233–1240.
36. Gregor MF, Hotamisligil GS. Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J Lipid Res 2007;48:1905–1914.
37. Boden G, Duan X, Homko C, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes 2008;57:2438–2444.
38. Magkos F, Fraterrigo G, Yoshino J, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab 2016;23:591–601.
39. Gregor MF, Yang L, Fabbrini E, et al. Endoplasmic reticulum stress is reduced in tissues of obese subjects after weight loss. Diabetes 2009;58:693–700.
40. Reeds DN, Cade WT, Patterson BW, Powderly WG, Klein S, Yarasheski KE. Whole-body proteolysis rate is elevated in HIV-associated insulin resistance. Diabetes 2006;55:2849–2855.